Plasma leptin levels in chronic heart failure: role of hyperinsulinemia and insulin resistance  by Leyva, F. et al.
248A ABSTRACTS - Po~,ler JACC February 1998 
duros Is available, ~D reconstruction capability Is another major advantages 
of this unique, now technology now tn a multlcontor clinical trial, 
~ Accuracy of MRI Evaluation of Pulmonary Blood 
Supply In Patlenti With Complex Pulmonary 
Steneala or Atresla 
A,J, Powell, 1", Chung, 1", Gave, Chlldren~ HosplfN, Harvard Merllcal 
School. Boston. MA, USA 
Backgrouncl: Oetalled Imaging of pulmonary artery (PA) anatomy end signif- 
Icant aortopuimonary collaterals (APCs) Is crucial for surgical planning and 
follow.up In pts with complex congenital head disease end pulmonsw stone. 
ale (PS) or atrosla (PAtr), Beonuse examination by echo Is often toQhnlcelly 
limited, this study evaluated the utlllty of MRI as an alternate non.lnvMIve 
Imaging foot, 
Method~: Tan pts (median ago 31 yra, range 1-4 yrs) with poor echo win. 
dows undenvont both cordlac catheterization (Garb) and MRI within ~ median 
of 3 roDS (range 0,1--8 roDS), Diagnoses Included TOF/PAtr (n - 6). TOF/PS 
(n = 2), single ventricle with PAir (n - t) and hetaretaxy syndrome with P8 (n 
.1), MRI was performed uaing EOG.gnted spin echo and gradient echo se- 
quences In standard and obllqu~ Imaging planes, Date ware retreapeetlvely 
oveluPdod using anglography ~t Oath eta the reference standard, 
R~Jiolt~: MRI hed 100% ~ensittvity ~nd speciti(~'lty for the dlngnosla el 
main PA (n ~ 5) ¢lnd branch PA hypoplnale or stenosls (n = 11), as well as 
discontinuous PAs (n .= 3), There was complete agrenment between MRI 
end C~th identification el slgnlti~nnt APCa (n ,~ 6), Main PA atrea~a was 
noted by MRI tn 4 pts but was not definitively shown by Cath in any, MRt 
but not C~th precisely delin~l the distance between discontinuous PAs and 
their relationl~hlp toother medlastinal structures, MRI and Ceth evaluation ot 
aortnpulmonan/or Glenn shunt potency was concordant n all eases (n = 4), 
Conc/~ton: Cardiac MRI Is a reliable non.lnvnt~lve imaging mod~llty to 
define PA and APC anatomy tn pts with complex PS or PAir, 
11095-160 ] Nonlnvaalva Automated Asse iament  of the 
Ratio of Pulmonary to Systemic Flow In Atrial 
Septal Defects by Spatlo-temporal Integration of 
Doppler Velocity Profile 
T, HozumL K, Yoshlda. Y. Ued& 1". Akasska, T. Takagi, S. Kali. 
1", Kawamoto, S. Morioka. Kobe Genera/Hospital. Kobe. Japan 
~ckg~ound: Convontlonal pulsed Doppler ochecardlographtc determination 
of the pulmonary to systemic blond flow (Qp/Qs) ratio ip patients (pts) with 
atrial septel detect (ASD) requires calculation of pulmona~/and aortic luminal 
areas and integrals of the Doppler velocity wave fu,m which are timo*consum- 
tng process, Recent introduction of automated cardiac output measurement 
(ACOM) method provides quick end accurate automated calculation ot car- 
disc output by spetio-tempornl integration o1 Doppler velocity prottl,~. In this 
study, we applied this new method to nontnvasive automated etem,nat~on 
oi Qp,K~!s by ACOM tn pts with ASD. 
Methods: We studied t5 pts with ASD who underwent cardiac catheleri- 
z~tton by color Doppler echocardlography, We evaluated Qp and Qs by ACM 
method, Qp was automatically calculated by setting a region of interest (ROI) 
on the pulmonary annulus tn the parastemal shoal-axis view. The calculation 
O1 Qs was automaticaUy performed by setting a ROt on the aortic annulus in 
the apical tong-axis view. At the time ot catheterization, Qp/Qs was assessed 
by oxlmetry. The Qp/Qs ratio determined by ACM method was compared 
with teat by oxlmetry. 
Results: The QplQs ratio determined by ACM method correlated well with 
the oxlmetric Qp/Qs ratio (r = 0,93. y = 0.83x + 0,15). 
Conclusion: New and simplified ACOM method appeam promising for the 
accurate noninvasive automated assessment of the Qp/Qs ratio in pts with 
ASD. 
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~9- - ]  Superoxlde Anion Generation by Neutrophils 
Correlates With NYHA Status In Chronic Heart 
Failure 
G.R. Ellis. D. Lang, RA. Anderson. S. Jackson, M.J. Lewis, 
M.P. Frenneaux. University of Wales College of Medicine. Cardiff. UK 
Background: Oxidative stress is increased in chronic heart failure (CHF) but 
the mechanism underlying this process is unclear. Neutrephll production of 
free radicals in particular euperexlde anion (O 2 ) may be an Important soume 
o! free radical generation In this disease. Employing a chemllumlnescent 
technique we measured O~ generation by neutrophlls via the NADPH/NADH 
oxldaso system from patients with CHF and correlated these findings with 
clinical NYHA status. 
MeteD(Is: We studied 10 CHF patients and 10 matched, healthy controls. 
Neutrephlls were separated from venous blood samples end their ability 
to generate O=~ detected utillslng luclgenln In a standard chemllumlnescont 
assay, The neutrophlls were stimulated with N.fomlyl.met.ieu.phe, BOth the 
peak level of O~ production end the elope of the dse to this peak were 
moeSurod, 
Re~ulla: Peak levels ol O~ generation and the slope of the d~e to this 
peak were slgnlfloantly greater In CHF patients (59.99 [8EM 11,13] v. 20,84 
[gEM 2,02], p ~ 0,005 and 1,03 (SEM 0.19] v, 0,30 [8EM 0,05], p ,~ 0,005, 
respectively). A good correlation was shown between peak O~ levels and 
NYHA statue In the patients (r = 0,78, p .  0,05), 
Discussion" This study supports the hypothesis that neutrephila ¢onl~bele 
ireportently to InQreased oxidative stress in CHF, The mechanists of the 
enhanced O~ generating ability el neutrephits remains to be determined, 
Turnout neomsis factor atph~ (TNF . )  has been shown to p,me neutruphds 
in rheum~told adhritls and is incre~IOd in head failure, padculady when 
severe, TNF t, and/or angi0tnnsln II may be impoflant in mediating increased 
superoxide anion generation in CHF 
Preo..,,,o Value o, C,,,=o,.,,., Levels o|  
Interfeukln-6 In Patlente With Con loat lve  Heart 
Failure 
E, Rotg. J. erda. C. Pa~, M, A~queta, F. Pi~rez.Vtlla. M. Hems. G. Sanz 
Hospafst Clin¢. Barcelona. Spain 
To assess the prognostic value oi increased plasma lntedeukin.6 ilL-6) 46 
patients (Pie) with congestive heart failure (CHF), (mean age 52 ± 9 years) 
werb studied. Plasma nourohormonos, plasma IU6, elect=on Iraction (EF). 
ond.di~'~tolic (EDL) and end-systolic (ESL) lett ventncular lengths were as- 
sessed. 1 i~a EF, EDL and ESL ware massassnd at 6 months el follow-up. 
Mean EF of the studied population was 25 -f 6%. Plasma IL-6 was hKjher 
--5 pg/ml (H-IL-6) in 26 Pts while it was in the normal range in the remam~j 
20. Pts with H-IL-6 had higher incidence of NYHA functKmal class (FC) Ill-IV 
(61% vs 20%, p = 0.005), There were no differences recalling basal EF. EDL 
and ESL between patients with normal or HelL-6, However, at 6 months. Pts 
with H-IL-6 had lower EF and larger EDL and ESL than their countemarls. 
EF (%) EDL fmmt ESL tram} 
Norm,U-IL-6 3B I 14 64 ~ 9 49 ~ 10 
H-IL-6 27 t 8" 71 * 7- 57 i 9"" 
'p - OO3,"p- 001 
Atrial natriuretic peptide and plasma main activity were higher in Pts with 
H-IL-6(57 t: 53vs31 t 18, p =O03and5.3 t 2vs 1.8 ± 7, p= 0.04. 
respectively). During follow-up (36 :i 6 m,) 2 Pts died and 10 had CHF. 
Pts with H-IL-6 had higher incidence of events (42% vs 5%. p = 0.001). 
Multivariate analysis identified FC Ill-IV (p = 0.002) and plasma IL-6 (p = 
0.05) as independent predictors of prognosis. In conclusion, in Pts with CHF: 
1/H-IL-6 was associated with lower EF and larger EDL and ESL at 6 months, 
2/Plasma IL-6 was identified as an independent predictor ot prognosis. 
• Plasma LepUn Levels in Chronic Heart Failure: 
Role of Hyperinsulinemia nd Insulin Resistance 
F. Leyva ~ 2. S.D. Anker I , I.F. Godsland ~, M. Gathei 3, J.C. Stevenson ~ .
Department of Cardiac Medicine, UK: : Wynn Department of Metabolic 
Medicine. ICSM, London, UK 
Background; Leptin, a proauct of the obese fob) gone. increases energy 
expenditure. In chronic heart failure (CHF), a hypercatabolic state, leptin 
concentrations relate positively to energy expenditure. Insulin increases lep. 
tin production and CHF is a hyperinsulinemic state. We considered that in 
CHF. plasma leptin levels might relate to plasma insulin and insulin sensitivity 
(si). 
Methods: ~.'~le patients with CHF (n = 22. aged 60.5 ± 2.3, LVEF 22 ± 
4%, mean ~- SEM) and 10 healthy controls, matched for age and both total 
(TBF) and regional body fat (dual energy X-ray absorptiometry), underwent 
measurement of fasting plasma teptin (RIA) and an i,v. glucose tolerance test 
(IVGTT). 
Results: Compared to controls, CHF patients had 46% higher fat-adjusted 
plasma leptin levels (p = 0.029). 59% higher WGTT insulin levels (p = 0.036) 
and a 66% lower Si (p = 0.002). In the CHF group, plasma leptin levels 
correlated with tasting insulin (r = 0.74. p < 0.001), IVGTT insulin (r = 0.70. p 
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= 0,001), and Si (r = -0,58, p = 0,008), but not with TBF, In pooled SubleCtS, 
St emerged as the strongesl predictor of plasma leptin levels (SC - 0 42, 
p = 0017), tndel0ondently of IVGTT insulin ($C = 0.34, p = 0055) and TBF 
(SC = 0.if ,  NS; iotnt R *~ = 051, p ~ 0001), 
Conc/us/ons Pohenls w!th CHF have elevated plasma leptin concentm- 
tlona, In CHF. pllem8 Mpttn levels am IX~ttively related to plasma insulin 
and Invef~ly related to lnaulin eensitlvity. These relationships may be of 
I~P~,~lttlk= illlgOffance (n the incro~0d enolgy expe~ure  0bsel'v0d in 
CHF- 
~ In~'flml~ Insulin and Glt~'o~ in L IN I I | I  Heart 
FIIlum (NF) 
N, Sl~kln, R,S, McKeh~. J, Roulnau, C, Slga~n, E Wm~:ek, S. Yusut 
~ ~ Month~l Heart mtr~te Montreal, Can~ 
~:~g~¢~:  AIl~Om~Mit~ Of g~go~e (G) and insulin (I) me,alarum may 
play a role in tt~ etlolog~ and [~resso l  0t HF This Shx/¥ examnad me 
prl~#lence and cknical cowelatmn of O and t abnon'nalities m a stal~le HF 
mhofL 
,q~th~/s- FaM~ G and I ~ were obtained on 664 HF pahenls age 
(sd) 64 (10), EF ~ (?), NYHA.FC 1/11.64%, III/1V-36% 
R'eeu,~ 177 patmnts (2?%) wore known to have ~tes  me,~tus (DM) 
O~ the remaining 487 paltents, 111 (2"~ ~-) had eke'sled G (>6.t raM), w~lh 
53 (11%) in the DM range (G ~70 raM) In patients w~hout known DM: the 
mean Go I (sd) Im,.els and faslmg insultn rasmfarce mde~, (FIRt = G . I,'25) 
were 5-8 (2) raM, 13.3 (19) mUlL and 3 7 (8) (normal (sd), I = 4 (7) mU/L, 
FIRI ,, 1.4 (1)), G and I levels ~ ~ m palmnts with NYHA ~1111nan 
NYHA ~11. In addition, a greater I ~  o~ patients wan NYHA ~111 had 
DM than NYI.,IA <_ IL (Table) 
mlhoul DM DM n (%i 
G (so') mM I (-~t mU/L FIRI (~1) 
NYHA -_1! ,5.611 0)" 102 t10 1)" 24 (2 8)" 100 (24)'" 
NNHA ~ III 63 t21) 196 (29,6) 6 2 (12 5) 77 (32l 
"p < 00001 (lOg clara). --p = 0 04 NYHA ~ II VS NYHA :lit 
C~'~:/usm~: G and I abnormalff~es are common in HF patmnts and appea~ 
to women as HF symptoms increase_ Tl~s suggests that abr~rmalmes of G 
or I are e~her a consequence of a pred~or of worsening symptoms of HF 
Furlhe~ study is needed to explem the role Of G and I abnon'naJilms in HF 
[ -~ '~ Pnognoslk~ Second Generation Cardiac Value of  
T ropon in  T in Patients W'dh Chron ic  Heart  Failure 
K. Setsuta ~ . T Ohtsuka ~ . T Ogawa ~ . Y Seine 2 . T. Takano 2 , K Se~m~va J 
N. Takahashr ~. H. K ~  ~ . H Hayakawa z . K. Sasak~  . A Ha~ada ~ .
' HakuFka~ Memorial General Hosp. ,~pan: :N, ppon Med~.cal Scttool Tok~o. 
Japan 
Back~ound: We pfevrously reported that cardrac IToponin T (Tnrl @elected 
by second generatmn assay elevated in l:~1~ents wTth severe chron¢ heart 
failure (CHF) and suggested that latent ~ myocaro~al damage generated 
in severe CHF patients. In the present study, we tested the hypothesis that 
TnT would be a prognostic marker ol CHF 
Methods.- We measured serum second generation TnT levels (Boehnnger 
Mannheim) in 50 patients with CHF and investigated the relationships be- 
tween cardiac event (death or admission because ot worsening CHI c) and 
TnT levels and other climcal parameters (NYHA class. CTR. LVEF and atnal 
natnuretic peptide level). 
Results: Over a follow-up of 3 ~ 27 months. 7 patients were died and 
9 patients were readmitted because of worsening CHF All died patients 
showed TnT ~0.04 ng/mL Cardiac event-free rate in patients w~th TnT 30.05 
rig/mr was signitmantly lower than that in patients w~th l"nT ~005 ng/ml (1 
year 27.3 vs 82.6%, p = 0.0003). In a multtvanate Cox properbonal hazard 
analysis, NYHA class (p = 0.02) and TnT ~-005 ng/ml (p = 0.002) were. 
significantty and independently correlated to cardiac event-free ~ate 
Conclusion: The present study suggests that elevated TnT level ~dentifies 
patients at increased risk of cardiac event. 
-~ ' -~-~ Growth Hormone Addit ion fo r  Pat ients  With 
Congest ive Heart Failure: A Randomized,  Placebo 
Control led Study With Recombinant  Human 
Growth Hormone in Patients With Congest ive 
Heart Failure and Without Growth Hormone 
Def ic iency  
C.-H. Berth, J. Isgaard, K. Caidahl. M. Lomsky, A. Hjalmarson, 
B,-A, Bengtsson. Sahlgrenska University Hospital. G~teborg. Sweden 
Background: Expenmental data in heart failure models, short term infusion 
m human congestive hear1 failure (CHF) and an open thai m pabems ~,tn 
idiopathic dilated card0omyopathy have demonstrated benet:oal effect: ol 
growlh hormone (GH) on cardiac lunctton 
Moth~tq Twenty I:~tmnts wffh mdd-moderale CHF (NYHA ClS~ It-II1! ot 
~chemtc (n = 8) or non . l~  (n = 14) OtK~gY, aed an ~ ttaclmn 
.45% were etuclH~ *n e 3 months double-blind and I~¢ebO contmae¢l real 
with recombinant hgman GH (thGH), They mcetyed e~er  ptacet~ (n ,= 10) 
or rt~;H (n ~ t0) in a dose 0! 0,! IF../kg/week for 1 week, end thema~ 
0,25 l ~ k  of # meslmel ~ i ly  ~ of 2 IE l ! ~ ,  Cafdmc 
hJfCtiofl wea ¢~termine¢l by (~Cluifltm~m ~ angiogtaphy at ~ 
e~ecme, and by 0oppler,eChccardiogm~y m rest, A ~m~l emil t~vcJe 
ex~se test and Ho~r ECG ~m 8~h~o ~m4 Pal~t~ were evaluatea t O, 
2 and 12 weeks afar ra~tat~n,  mspectNety 
Resu/M Them was a signltlcanl i ~  . I  insulin like growlh ta¢~ I O! 
140% m the GH group at 3 monthe compcq~ Io ~h~_-q~!ina, F~cellent p,~mm 
comp*~,c@, no ~ s  adveme eveme and no ~gmfcant i ~  in vem~c, 
ular army~mlas in the GH grote, ~red  to placebo were found, However 
no significant effect o! d~GH on systol~ Or ~¢¢ hmctlon, or maximal ex, 
e~se  capacity were found. Neither did NYHA hmct~nai ¢la~7.atK)n nor 
~rade ,n~rove 
ConctuSK~: Th*s ,s the first double blind and placebo controlled stuo'y o! 
long 8me rhGH adrninislratmn m pat~'nts ~ CHF ot dtflemm et~ologms 
The treatment was safe and w~mul senous adverse events However no 
po~dwe cardiac effecls were found. 
~ Sponlaneous Nocturnal Growth Hormone (GH) 
SecreHon and t!mm~ly~mk: Profile in Chronic 
Heart Failure (CHF) PMkmts 
M Vofterran,. A_ G~ustma ~. R. Longing, A. Gmrdano. "S,~vamm Maugen" 
Four~,  IRCCS. Gussago Medial Centre, Italy; ' Llnn~n;tty ot Breech, 
Endocnnotogy dep. Ira~y: "~ Spedall Cw~h d* gresOa, Cam~surgery It dep. 
Baotgroun.2 CHF ~s charactensed by acttvatmn of neursendoome system 
proport~nal 1O climcal seven~/, In urneared CHF pts GH level was found 
t~jher than in nomnal sub,~'ts NO data am available on GH eecretmn pm~le 
in trealed pts with severe hearl fa~ure. A~m of our study was Io assess: t ) 
GH sec~tmn nocturnal profile rn CHF pts m c,..~l.,ansen to normal su0fects 
2) ~ relatmnshq3 belween GH, insulin gmwlh factor 1 IGF.1. noradranaline 
NA. ad~enaflne A. a~nal natnurebc taclor ANP and the haemodynaro~ profile 
rn m~S pts. 
Meff/o:/s: In 7 noroval sul~ecls age-matched, and ~ 12 males, w~h 
~schaem¢ CHF, mean age 63 : 7. mean EF (ECHO) 20.6 ~ 65%, m ~able 
standard chronic merapy we evaluated overn~ghl (evew 20 mm from 10 pm 
to 6 am.) spontaneous GH secret~ (IRMA. N¢t'~s), baseline IGF-t (RIA, 
N'~'hols~ after ac~d-ettlanot extraction} and, only mplS, neuroendocllne pro~le 
and haemodynarmc parameters wa Swan*Ganz nghl hear cathefenzatlonr 
Results Th~ mean nocturnal GH level iS h*gher m pts compared w~ 
control group (1.4 ~ 0.6vs2.5 ± 13). We d~ net found any differences 
re* tGF-I level between the two groups. Accondmg w~th ~ aub~ GH 
mean nocturnal value, percents were d~ded in two subgroups (5 pls vs 7 
10is). Those with higher me~ spontaneous GH level (3.3 • 1 1 vs IA  t 
0.8 u/I) have lower IGF-1 level (119 ± 63 vs 2368 ± 35.9 ud) and a worse 
haernodynamic profile (mean PAP 44 ± 6 vs 30 ~: 10 mmHg; PCWP 29 ± 6 
vs 17 ± 7 mmHg; CO31 ± 1 vs4.8 -+ 1 L, Ynm; PVR440 ± 138 vs 267 :~ 123 
dme/cm2/sec-5) and higher symphatettc actnration (NA 734 + 303 vs 436 ± 
132. A88 ~ 60 vs60 ± 34, ANP 344 ± 184 vs 214 ± 174), 
Conc/us~ts: Our results shown that 1) CHF parleys shown on average 
a higher nocturnal GH secretion respect to normal subjects 2) among this 
patients, those with normal GH nocturnal secretion have luss severe haemo- 
dynamic picture and reduced sympathetic hyperactivation secretion respect 
to normal sublects 2) among this patients, those w~th normal GH nocturnal 
secretion h;~ve 10.% severe heemodynamic prcture ~nd reduced sympathetic 
hyperactreation. 
11096-36 } c,w,~.-sto~.~ ,. .~,o,,  .o~,g A.,,k,, . .  
Day-Time in Chronic Heart Failure: Prognostic 
Impl icat ion 
~. Mortara. G,D Pinna, R Maestn. MT La R,',verc, E Traverse. C Opasich. 
P. Steight ~ . L. Tavazzi Department of Cardiology. "S. Maugeri" FoundaPton. 
Montescano, Pavia. Ira~y: ~ John Radcliffe HospffaL Oxford. UK 
It has been shown that in chronic head failure (CHF). respiratory disorders 
such as Cheyne-Stokes (CS) and periodic breathing !PB). which are a fte- 
quent event during sleep, may occur even dunng day-time in patients [gts) 
with compensated heart failure. These alterations of breathing cause further 
ventricular impairment and sympatt'mtic hyperaclivation, but their impact on 
survival is still debated. To address the assooation between awake breathing 
disorders and shod-term prognosis 15- = moderate to severn CHF pts (mEan 
